Site icon Iconic Lady

Gilead Sciences’ chatbot to support healthcare providers within the GCC and Levant

Gilead Sciences’ chatbot to support healthcare providers within the GCC and Levant with scientific updates on COVID-19

Come Chat will support the regional medical community with quick access to published data on COVID-19 management

Dubai, 11 October 2021: Gilead Sciences has launched (COVID-19 Middle East Chatbot) Come Chat, an application that hosts relevant scientific updates and the latest international management guidelines on COVID-19 treatment. The guidelines include those on the timely use of antivirals medications for COVID-19 and is aimed to be used ONLY by healthcare providers (HCPs) practicing within the GCC and Levant.

Gilead Sciences has been a pioneer in manufacturing antivirals for more than 30 years. Come Chat is a tool that supports practicing HCPs with standardized and peer-reviewed clinical and non-clinical  studies. The platform is available both on Google Play and App Stores and as a desktop version, covering the most up-to-date clinical COVID-19 data, including safety and efficacy information from global published clinical trials.

Frederico Silva, General Manager, Gilead Sciences, Middle East said,  “Ever since the novel coronavirus that causes COVID-19 was identified, the team has been working to support governments and the medical community with our decades of expertise in antiviral research and development.  The more than a decade worth of investment and research on Gilead’s antivirals has been critical in our progress in treating COVID-19 and to help meet patient needs. True to our purpose Creating Possible, through Come Chat that employs state-of-the-art machine learning technology, we want to support healthcare professionals by closing any information gaps to ensure better patient outcomes.”

Dr Ahmad Subhi, Consultant Infectious Diseases and Head of Infection Prevention and Control Unit at Al Qassimi Hospital, said: “It is important for the healthcare sector to work on standardized processes and procedures to ensure patients’ welfare. The pandemic has introduced unprecedented challenges to the healthcare system and brought with it a steep learning curve. Easy access to scientific information on mobile devices through platforms such as Come Chat will help trained clinicians to make informed choices for driving better outcomes for their patients.”

Scientific information will constantly be updated on Come Chat as the COVID-19 pandemic continues to drive data and learnings to clinicians worldwide. Come Chat covers a wide variety of information on COVID-19 including but not limited to international and local guidelines, key published studies on all related treatments, new virus variants and more.

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Exit mobile version